Tweet
<img alt="" height="1" width="1" />
Pfizer halts study of lymphoma drug unlikely to help survival
Reuters
Mon May 20, 2013 5:57pm EDT. (Reuters) - Pfizer Inc, which has been on a hot streak with three recent approvals of cancer drugs, stumbled on Monday, saying it was halting a late-stage trial of a drug for aggressive non-Hodgkin lymphoma after independent ...
Pfizer (PFE) says it's discontinuing Phase 3 studies on its investigational ...Seeking Alpha
Pfizer (PFE) Discontinues Inotuzumab Development Following Phase 3StreetInsider.com (subscription)
all 3 news articles »
More...